EP3897958A1 - Method and device for producing saccharides and saccharide arrays - Google Patents
Method and device for producing saccharides and saccharide arraysInfo
- Publication number
- EP3897958A1 EP3897958A1 EP19832336.2A EP19832336A EP3897958A1 EP 3897958 A1 EP3897958 A1 EP 3897958A1 EP 19832336 A EP19832336 A EP 19832336A EP 3897958 A1 EP3897958 A1 EP 3897958A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- saccharide
- solid support
- vapor
- immobilized
- acceptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J19/0046—Sequential or parallel reactions, e.g. for the synthesis of polypeptides or polynucleotides; Apparatus and devices for combinatorial chemistry or for making molecular arrays
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00351—Means for dispensing and evacuation of reagents
- B01J2219/00387—Applications using probes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00495—Means for heating or cooling the reaction vessels
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00497—Features relating to the solid phase supports
- B01J2219/00527—Sheets
- B01J2219/00533—Sheets essentially rectangular
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00596—Solid-phase processes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00659—Two-dimensional arrays
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00675—In-situ synthesis on the substrate
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00718—Type of compounds synthesised
- B01J2219/0072—Organic compounds
- B01J2219/00731—Saccharides
Definitions
- the present invention relates to a method and a device for producing saccharides and saccharide arrays. Said method is particularly useful for the synthesis of saccharides in parallel and of high-density saccharide arrays, such as microarrays, which are required for high-throughput screenings.
- High-throughput screenings of large chemical libraries with hundreds of thousands to millions of different molecules are established as a standard method in drug discovery.
- the screening of highly diverse and large chemical libraries for molecular interactions promises the discovery of new drug candidates or, in the case of carbohydrate and peptide libraries, for example, the identification of new biomarkers for the development of diagnostics or vaccines.
- the costs for the synthesis of complex chemical substance libraries are very high ⁇ up to thousands of euros per substance), so that only larger pharmaceutical companies have access to such complex chemical libraries. This prevents advancements in both fundamental research ⁇ e.g., understanding development of immunity or disease progression), as well as applied research and development ⁇ e.g., new biomarkers). Therefore, there is a high demand for a cost-efficient method for synthesizing minute amounts of chemical compounds on demand and for performing miniaturized and highly parallelized screenings.
- Saccharides are an important class of vaccines and antibody binders. However, the exact structures are often unknown, due to the lack of availability ( Chem Biol, 2014, 38-50). High-density saccharide arrays are therefore required to detect these important antibodies and distinguish between those that fight infection and those that are harmful:
- the cost-effective access to high-density saccharide array would allow (i) the identification of valuable biomarkers for diagnostics, such as a saccharide derived from an antibiotic-resistant bacterium that binds to an antibody, (ii) would lead to improved diagnostics of the course of a disease (by identifying newly formed antibodies in a patient that correlate with disease status), (iii) would facilitate the development of rationally designed vaccines (by identifying antibodies and their glycan targets in immune patients), and, (iv) would assist finding new targets for therapy (e.g., by identifying damage-inducing autoantibodies).
- the inventors have established a parallelized high-throughput saccharide synthesis on a solid support by first applying the saccharide building blocks on the solid support and subsequently carrying out the coupling reaction.
- the coupling reaction such as a glycosylation reaction, is carried out by exposing the saccharide building blocks applied on the solid support to a vapor comprising a solvent and a coupling reagent at low temperatures. The vapor condenses on the solid support and initiates the coupling reaction, thereby allowing the simultaneous synthesis of different saccharides at discrete locations on the solid support.
- the present invention is directed to a method for synthesizing saccharides comprising the steps:
- the present invention is directed to a method for synthesizing saccharides comprising the steps:
- the present invention is directed to a method for synthesizing saccharides comprising the steps:
- the present invention is also directed to a method for synthesizing saccharides comprising the steps: A) providing a solid support with at least one immobilized acceptor group for reacting with a saccharide;
- immobilized acceptor group is located at discrete locations forming an array on the solid support.
- the present invention is directed to a method for producing saccharide arrays comprising the steps:
- the coupling reaction in step C) is carried out at a temperature below 5 °C, more preferably below 0°C, more preferably between -78 °C and 0 °C and most preferably between -20 °C and 0 °C, due to the high reactivity of the glycosylation reagent.
- the present invention is directed to a method for synthesizing saccharides comprising the steps:
- present invention is directed to a method for synthesizing saccharides comprising the steps:
- the ratio of the solvent and the glycosylation reagent in the vapor is in the range of 1 :10 to 100,000:1.
- the present invention is directed to a method for synthesizing saccharides comprising the steps:
- the solvent used for the vapor is an aprotic organic solvent.
- the solvent is selected from: methylene chloride, acetonitrile, chloroform, diethyl ether, 1 ,4-dioxane, methyl tert-butyl ether, toluene and ethyl acetate.
- the glycosylation reagent used in the herein described methods, is a Lewis acid.
- the glycosylation reagent is selected from: AgOTf, BF 3* OEt 2 , trimethylsilyl trifluoromethanesulfonate (TMSOTf), trifluoro- methanesulfonic acid (TfOH), trifluoromethanesulfonic anhydride (Tf 2 0, triflic anhydride), lanthanoid(lll) triflates, NIS/AgOTf, NIS/TfOH or dimethyl(methylthio)- sulfonium trifluoromethanesulfonate (DMTST).
- TMSOTf trimethylsilyl trifluoromethanesulfonate
- TfOH trifluoro- methanesulfonic acid
- Tf 2 trifluoromethanesulfonic anhydride
- DMTST dimethyl(methylthio)- sulfonium trifluo
- the glycosylation reagent is selected from: trimethylsilyl trifluoromethanesulfonate (TMSOTf), trifluoro methanesulfonic acid (TfOH), trifluoromethanesulfonic anhydride (Tf 2 0, triflic anhydride), and NIS/TfOFI.
- TMSOTf trimethylsilyl trifluoromethanesulfonate
- TfOH trifluoro methanesulfonic acid
- Tf 2 trifluoromethanesulfonic anhydride
- NIS/TfOFI NIS/TfOFI
- glycosylation reagent is a Lewis acid selected from: AgOTf, BF 3* OEt 2 , trimethylsilyl trifluoromethanesulfonate (TMSOTf), trifluoromethanesulfonic acid (TfOH), trifluoromethanesulfonic anhydride (Tf 2 0, triflic anhydride), lanthanoid(lll) triflates, NIS/AgOTf, NIS/TfOH or dimethyl(methylthio)sulfonium trifluoromethane sulfonate (DMTST).
- TMSOTf trimethylsilyl trifluoromethanesulfonate
- TfOH trifluoromethanesulfonic acid
- Tf 2 trifluoromethanesulfonic anhydride
- DMTST dimethyl(methylthio)sulfonium trifluoromethane sulfonate
- delivering the saccharide onto the solid support refers preferably to a solution of the saccharide which is applied onto the solid support.
- the term “delivering the saccharide onto the solid support” as used herein can, for the preferred embodiments, be replaced by the term “applying a solution of the saccharide onto the solid support”.
- the solid support is dried by evaporating the solvent. After the drying process or the solvent evaporation process, the saccharide remains on the solid support but without solvent so that free moving of the saccharide in a solvent is no longer possible.
- the saccharide, used in the herein described methods is a protected glycosyl donor comprising a glycal, epoxide or orthoester group or a protected glycosyl donor having a leaving group at the reducing end.
- the present invention is directed to a method for synthesizing saccharides comprising the steps:
- R 5 represents an alkyl or aryl group.
- step B) of the herein described methods the saccharide can be delivered or applied or deposited or transferred with any known method from the art onto the solid support. This includes delivering the saccharide as a solid, from a solution or in a polymer matrix onto the solid support.
- the method for synthesizing saccharides comprises the steps:
- step B) applying a vapor of a solution of a glycosylation reagent in a solvent onto the solid support at a temperature below 20 °C in order to initiate a coupling reaction of the saccharide to the at least one immobilized acceptor group; wherein in step B) the saccharide is present as a solid, in a solution or in a polymer matrix onto the solid support.
- the delivered saccharide is dried prior to initiating the coupling reaction in step C) in order to obtain higher reaction yields and less side products due to any water or moisture present.
- the saccharide is dried under reduced pressure and/or heating.
- the method for synthesizing saccharides comprises the steps:
- saccharide refers to but is not restricted to monosaccharide, disaccharide, trisaccharide, tetrasaccharide, pentasaccharide, hexasaccharide, heptasaccharide, octasaccharide, oligosaccharide, polysaccharide and glycan.
- the saccharide comprises preferably at least one of monosaccharide units selected from:
- saccharides, and monosaccharides, monosaccharide units are optionally protected with the appropriate protecting groups as defined below.
- the saccharides are further optionally modified to carry amide, carbonate, carbamate, carbonyl, thiocarbonyl, carboxy, thiocarboxy, ester, thioester, ether, epoxy, hydroxyalkyl, alkylenyl, phenylene, alkenyl, imino, imide, isourea, thiocarbamate, thiourea and/or urea moieties.
- protecting group refers to commonly used groups in organic synthesis, preferably used for protection of amines, hydroxyl groups, thiols, imines, carbonyls, carboxyls or other common functional groups, and particularly preferred for amines and hydroxyl groups.
- the protecting groups are characterized in that they are stable under reaction conditions applied during the synthesis, i.e. they are not cleaved off or undergo undesired side reactions and prevent any reaction of the protected functional group they are bonded to. Additionally, the protecting groups are selected to not hinder or to not affect the performed reaction steps in terms of yield or stereoselectivity.
- Preferred protecting groups for hydroxyl groups are acetyl, phenyl, benzyl, isopropylidene, benzylidene, benzoyl, p-methoxybenzyl, p-methoxybenzylidene, p-methoxyphenyl, p-bromobenzylidene, p-nitrophenyl, allyl, allyloxycarbonyl, monochloroacetyl, isopropyl, p-bromobenzyl, dimethoxytrityl, trityl, 2-naphthylmethyl, pivaloyl, triisopropylsilyl, fe f-butyldimethylsilyl, fe/f-butyldiphenylsilyl, tert- butyl- methoxyphenylsilyl, triethylsilyl, trimethylsilyl, 2-trimethylsilylethoxymethyl, 9-
- Preferred protecting groups for amine groups are acetyl, benzyl, p-methoxyphenyl, benzoyl, p-methoxybenzyl, 3,4-dimethoxybenzyl, benzyloxycarbonyl(Cbz), allyloxycarbonyl, trichloroacetyl (TCA), trifluoroacetyl, trichloroethyl(Troc), p- bromobenzyl, dimethoxytrityl, trityl, 2-naphthylmethyl, pivaloyl, 9- fluorenylmethoxycarbonyl (Fmoc), tert-butyloxycarbonyl(BOC), levulinoyl, tosyl, nosyl, 2-nitrophenylsulfenyl (Nps), and phthalimidyl.
- the protecting groups can be differentiated in "permanent protecting groups” and "temporary protecting groups".
- Permanent protecting groups are protecting groups that are stable during the entire synthesis and that can be efficiently removed at the late stage of the synthesis. In this case, permanent protecting groups are masking the hydroxyl groups and amino groups, if present, during the entire synthesis.
- permanent protecting groups are benzyl, benzoyl, acetyl, allyloxycarbonyl (alloc) and benzyloxycarbonyl group (Cbz).
- the temporary protecting groups are generally orthogonal protecting groups that can be selectively removed at different levels of the synthesis to free hydroxyl groups for subsequent introduction of different substituents, including monosaccharides, other protecting groups or other residues present on the molecule.
- Temporary protecting groups are preferably selected from, but are not restricted to: allyl, p-methoxybenzyl, 2-naphthylmethyl, tri-isopropylsilyl, fe/f-butyldimethylsilyl, fe/f-butylmethoxyphenyl- silyl, triethylsilyl, trimethylsilyl, 2-trimethylsilylethoxymethyl, 9-fluorenylmethoxy- carbonyl and levulinoyl.
- protecting groups allow expedient access to a library of saccharides. It is apparent for a skilled person to choose the protecting groups in such a manner that they can be removed from the saccharide without cleaving the saccharide from the solid support.
- R 5 may be any alkyl or aryl group.
- acceptor or "glycosyl acceptor” refers to a saccharide that contains at least one free hydroxy or amine function and is capable of forming a glycosidic bond with a glycosyl donor under suitable reaction conditions.
- saccharide building block or “building block” refers to a saccharide acceptor or saccharide donor, i.e. to a saccharide that is capable of forming a glycosidic bond when being exposed to a vapor comprising a solution of a glycosylating agent.
- the saccharide building block can be fully protected (i.e. each hydroxy or amino group is blocked by a protecting group), partially protected (i.e. at least one hydroxy or amino groups is blocked by a protecting group) or unprotected (i.e. none of hydroxy or amino groups is blocked by a protecting group).
- the saccharide building block may also be modified at the reducing end with a suitable functional group such as a carboxylic acid (e.g. hydroxyacetate), azide, alkyne, thiol or an amine (e.g. aminopropyl or aminopentyl).
- a suitable functional group such as a carboxylic acid (e.g. hydroxyacetate), azide, alkyne, thiol or an amine (e.g. aminopropyl or aminopentyl).
- Any known saccharide building block can be employed in the inventive methods described herein, including saccharides, glycopeptides or glycopeptoids as described in Beilstein J. Org. Chem. 2014, 10, 2453-2460.
- the term“coupling reaction”, as used herein, refers to reactions between a glycosyl donor and a glycosyl acceptor, wherein the reducing end of the donor reacts with a free hydroxy or amine group of the acceptor.
- O-glycosylation or /V-glycosylation methods are preferably employed in the coupling reaction of the method according to the invention. More preferably, O-glycosylation methods are employed in the coupling reaction of the method according to the invention.
- These glycosylation methods are known from the state of the art. Generally, they require a leaving group at the reducing end of the donor, which is activated in the presence of a catalyst.
- glycosylation reactions take place upon treatment of a donor and an acceptor with a "glycosylation reagent" which acts as an activator or an activating agent.
- Glycosylation reagents known to the skilled person include, but are not restricted to: AgOTf, BF 3* OEt 2 , trimethylsilyl trifluoromethanesulfonate (TMSOTf), trifluoromethanesulfonic acid (TfOH), trifluoromethanesulfonic anhydride (Tf 2 0, triflic anhydride), lanthanoid(lll) triflates, NIS/AgOTf, NIS/TfOH or dimethyl(methylthio)- sulfonium trifluoromethanesulfonate (DMTST).
- solid support refers to an insoluble, functionalized, polymeric material to which saccharides or other reagents may be attached or immobilized, directly or via a linker bearing an anchoring group, allowing saccharides to be readily separated (by washing, filtration, centrifugation, etc.) from excess reagents, soluble reaction by-products, or solvents.
- the solid support has preferably the form of a plate or a membrane.
- saccharide array is understood as meaning a saccharide library bound to a solid support, wherein the saccharide library includes the totality of many different saccharides bound to defined sites of the solid support, the so called discrete locations or spots.
- saccharide array is uses synonymously to saccharide array.
- high-density saccharide array refers to a saccharide array having a pitch of preferably less than 300 pm, more preferably less than 200 pm, more preferably less than 150 pm and most preferably less than 100 pm.
- the pitch is defined by the spacing of individual locations or spots measured from the midpoint.
- Alkyl refers to saturated hydrocarbon groups of from 1 to 18 carbon atoms, either straight chained or branched, more preferably from 1 to 8 carbon atoms, and most preferably 1 to 6 carbon atoms.
- An alkyl with a specified number of carbon atoms is denoted as C-i-C 8 alkyl and refers to a linear C-i-C 8 alkyl of -CH 3 , -C 2 H 5 , -C 3 H 7 ,
- Aryl refers to an unsaturated aromatic carbocyclic group of from 6 to 12 carbon atoms inclusively having a single ring (e.g phenyl) or multiple condensed rings (e.g naphthyl or anthryl).
- exemplary aryls include phenyl, pyridyl, naphthyl and the like.
- Vapor refers to substance or substance mixture in the gas phase at a temperature lower than its critical temperature, thereby allowing the gas to condense at increased pressure or on a surface having a lower temperature than the vapor.
- the vapor used in the present invention comprises at least one aprotic organic solvent and at least one glycosylation reagent.
- the at least one aprotic organic solvent and/or the at least one glycosylation reagent may also be present in the vapor as tiny particles of liquid, solid, or both, thus forming a suspension or aerosol or fog.
- the vapor is formed from a mixture or solution of at least one aprotic organic solvent at least one glycosylation reagent by heating and/or under reduced pressure. Due to the evaporation of the volatile organic solvent, the at least one glycosylation reagent moves into gas phase, too.
- Solid supports for immobilization of carbohydrates or peptides are well-known in the art.
- Various methods for immobilization of mono- and oligosaccharides to solid supports are well known in the art and described in e.g. QSAR Comb. Sci. 25, 2006, No. 11 , 1033 - 1038.
- any common solid support with acceptor groups or anchor groups suitable for glycan microarrays can be used within the present invention, including commercially available amino-PEG cellulose membranes, hydroxyl-modified polypropylene membranes, microarray slides, including but not restricting to Corning® epoxide coated slides or Corning® GAPSTM II coated slides, CodeLink® NHS slides, N-hydroxysuccinimide-activated, epoxy-, amino-, carboxy-, aldehyde-, thiol-, or maleimide-functionalized glass slides, CPG, or aluminium oxide.
- Suitable for glycan microarrays means here that the solid support, e.g. the slide or membrane, needs to be resistant under glycosylation conditions as well as during the deprotection of the orthogonal protecting groups. Finally, it also has to give the possibility to cleave the final saccharides from the membrane for subsequent applications.
- Said solid supports present on their surface an acceptor group for reacting with a saccharide, i.e. a functionality that is prone to react with a hydroxy group or leaving group of a saccharide employed in the methods described herein, or with a functional group U of an interconnecting molecule (see Figure 4) to provide modified solid supports, presenting on their surface an acceptor group of the interconnecting molecule that can further react with a hydroxy group or leaving group of a saccharide.
- the acceptor groups are suitable for immobilizing saccharides on solid supports and are herein synonymously termed as "anchor groups".
- Suitable acceptor groups on solid supports include but are not restricted to are amino, thiol, hydroxy, N-hydroxysuccinimidyl, carboxy, oxime, epoxy or hydrazide groups (see Figure 3).
- the acceptor group may also be a saccharide, particularly a monosaccharide as listed above, or a disaccharide consisting of monosaccharide units as listed above, bound either directly or via an interconnecting molecule to the surface of the solid support.
- the acceptor group may also be a glycosyl acceptor comprising such a saccharide. In this case, the glycosyl acceptor forms a part of the saccharide to be synthesized.
- the glycosyl acceptor contains at least one free hydroxy or amine function and is capable of forming a glycosidic bond with a saccharide under suitable reaction conditions.
- Suitable acceptor groups are for instance 1 -oxyacetates as shown in Figure 5.
- the acceptor group may comprise a glycosyl acceptor of the following formula:
- S represents a monosaccharide selected from
- P 2 , P 3 , P 4 and P 6 represent independently of each other protecting groups
- L is a linker
- E represents amino, thiol, hydroxy, N-hydroxysuccinimidyl, carboxylate, carboxylic acid, oxime, epoxy or hydrazide.
- P 2 is a protecting group for a hydroxy group or a protecting group for an amine group
- P 3 , P 4 and P 5 represent protecting groups for a hydroxyl group
- the protecting group for a hydroxy group is selected from the group consisting of : acetyl, phenyl, benzyl, isopropylidene, benzylidene, benzoyl, p- methoxybenzyl, p-methoxybenzylidene, p-methoxyphenyl, p-bromobenzylidene, p- nitrophenyl, allyl, allyloxycarbonyl, monochloroacetyl, isopropyl, p-bromobenzyl, dimethoxytrityl, trityl, 2-naphthylmethyl, pivaloyl, triisopropylsilyl, tert- butyldimethylsilyl, fe/f-butyldiphenylsilyl, fe/f-butylmethoxyphenylsilyl, triethylsilyl, trimethylsilyl, 2-trime
- the protecting group for an amine group is selected from acetyl, benzyl, p- methoxyphenyl, benzoyl, p-methoxybenzyl, 3,4-dimethoxybenzyl, benzyloxycarbonyl(Cbz), allyloxycarbonyl, trichloroacetyl (TCA), trifluoroacetyl, trichloroethyl(Troc), p-bromobenzyl, dimethoxytrityl, trityl, 2-naphthylmethyl, pivaloyl, 9-fluorenylmethoxycarbonyl (Fmoc), tert-butyloxycarbonyl(BOC), levulinoyl, tosyl, nosyl, 2-nitrophenylsulfenyl (Nps), and phthalimidyl.
- the linker -L- is selected from: -L a - — L a — L e — , -L a -L b -L e -,
- -L a - is selected from: -(CH 2 ) 0 - -(CFI 2 -CFI 2 -0) o -C 2 Fl 4 -, -(CH 2 -CH 2 -0) 0 -CH 2 ; -L b - represents -0-;
- -L d - is selected from -(CH 2 ) q -, -(CF 2 ) q -, -(CH 2 -CH 2 -0) q -C 2 H 4 -, and
- -L e - is selected from: — (CH 2 ) PI — , -(CF 2 ) PI -, -C 2 Fl 4 -(0-CFI 2 -CFI 2 ) pi -,
- o, q, p1 and p2 are independently of each other an integer selected from 1 , 2, 3, 4, 5, and 6.
- -L- represents -(CFI 2 ) o - and o is an integer selected from 1 2, 3, 4, 5 and 6.
- -L- represents -(CFI 2 ) o - and o is an integer selected from 1 , 2, 3 and 4.
- the present invention is directed to a method for synthesizing saccharides comprising the steps:
- solid support is an insoluble, functionalized, polymeric material to which saccharides or other reagents are attached or immobilized, directly or via a linker bearing an anchoring group, in particular, selected from amino-PEG cellulose membranes, hydroxyl-modified polypropylene membranes, and microarray slides.
- the present invention is directed to a method for synthesizing saccharides comprising the steps: A) providing a solid support with at least one immobilized acceptor group for reacting with a saccharide;
- the at least one immobilized acceptor group has the following formula
- the interconnecting molecule may be chosen in such a manner that it facilitates the identification of synthesized saccharides after cleavage from the solid support via mass spectrometry (MALDI-TOF-MS) by enhancing the molecular weight of the saccharide.
- the interconnecting molecule may also be photocleavable, such as the nitrobenzyl linker shown below, for obtaining saccharides with a free reducing end after cleavage from the solid support.
- the coupling reaction is carried out by exposing the saccharide building blocks applied on the solid support to a vapor comprising a solvent and a coupling reagent at low temperatures.
- the vapor condenses on the solid support and initiates the coupling reaction.
- the next saccharide building block is applied on the solid support and exposed to the vapor comprising a solvent and a glycosylating agent.
- one aspect of the present invention is directed to a method for synthesizing saccharides comprising the steps:
- the method of the present invention gives access to saccharides of various lengths, including but not restricting to disaccharide, trisaccharide, tetrasaccharide, pentasaccharide, hexasaccharide, heptasaccharide, octasaccharide... , oligosaccharide, glycans, and polysaccharide.
- the method of the present invention gives access to bacterial capsular saccharides, saccharides of a viral glycoprotein, saccharide antigens of sporozoa or parasites, saccharide antigens of pathogenic fungi, and saccharide antigens which are specific to cancer cells.
- the bacterial capsular saccharides belong preferably to bacteria selected from:
- Allochromatium vinosum Acinetobacter baumanii, Bacillus anthracis, Campylobacter jejuni, Clostridium spp., Clostridium difficile, Citrobacter spp., Escherichia coli, Enterobacter spp., Enterococcus faecalis., Enterococcus faecium, Francisella tularensis, Haemophilus influenzae, Helicobacter pylori, Klebsiella spp., Klebsiella pneumoniae, Listeria monocytogenes, Moraxella catharralis, Mycobacterium tuberculosis, Neisseria meningitidis, Neisseria gonorrhoeae, Proteus mirabilis, Proteus vulgaris, Pseudomonas aeruginosa, Salmonella spp., Salmonella typhi, Serratia spp., Shigella spp., St
- the saccharides of viral glycoproteins belong preferably to viruses selected from: Adenoviruses, Ebolavirus, Epstein-Barr-virus, Flavivirus, TBE-virus, Influenza virus, Hanta-virus, human immunodeficiency virus ("HIV"), herpes simplex virus ("HSV", type 1 or 2), human herpes virus 6 (HHV-6), human Papilloma virus ("HPV", type 16 or 18), human Cytomegalovirus ("HCMV”), human hepatitis B or C virus (“HBV”, Type B; "HCV", type C), Lassavirus, Lyssavirus (EBL 1 or EBL 2), Marburgvirus, Norovirus, Parvovirus B19, Pestvirus, Poliovirus, Rhinovirus, Rotaviruses, SARS-associated Coronavirus, and Varicella-Zoster virus.
- viruses selected from: Adenoviruses, Ebolavirus, Epstein-Barr-virus, Flavivirus, TBE-virus, Influenza virus,
- saccharide antigens of sporozoa or parasites belong preferably to sporozoa or parasites selected from:
- Babesia Balantidium, Besnoitia, Blastocystis, Coccidia, Cryptosporidium, Cytauxzoon, Cyclospora, Dientamoeba, Eimeria, Entamoeba, Enterocytozoon, Enzephalitozoon, Eperythrozoon, Giardia, Hammondia, Isospora, Leishmania, Microsporidia, Naegleria, Plasmodium, Plasmodium falciparum, Plasmodium vivax, Plasmodium ovale, Plasmodium malariae, Plasmodium knowlesi, Pneumocystis, Schistosoma, Sarcocystis, Theileria, Trichinella, Toxoplasma, Trichomonas, Trypanosoma, Unicaria, Cestoda, Dipylidium, Dranunculus, Echinococcus, Fasciola, Fasciolopsis, Taenia, Ancylostom
- the saccharide antigens of fungi belong preferably to fungi selected from:
- saccharide antigens which are specific to cancer cells belong preferably to the group of cancers selected from:
- the saccharide, first saccharide or further saccharide can be delivered onto the solid support by any conventional technique known in the art, including dipping, spraying, spotting (SPOT, Tetrahedron 48, 9217-9232 (1992)), photolithographic techniques (Nat. Commun.
- the saccharide, first saccharide or further saccharide can be delivered or applied onto the solid support as a solid, in form of a solution or suspension, or in a polymer matrix.
- a subsequent drying step C), CT), C2'), or C3' should be performed in order to remove (i.e. evaporate) solvent, water or any moisture.
- the drying step comprises
- the drying step comprises:
- the drying step comprises:
- the drying step comprises:
- a drying step can nevertheless also be performed when the saccharide is delivered in any other form, such as a solid or embedded in a polymer matrix.
- drying step comprises:
- the drying step comprises:
- the drying step comprises:
- the method for synthesizing saccharides comprises the steps:
- the saccharide, first saccharide and/or further saccharide is a saccharide building block.
- the saccharide, first saccharide and/or further saccharide is a glycosyl donor.
- the saccharide, first saccharide and/or further saccharide is a protected glycosyl donor.
- the saccharide, first saccharide and/or further saccharide is a glycosyl donor comprising a glycal, epoxide or orthoester group or having a leaving group at its reducing end selected from
- R 5 represents an alkyl or aryl group.
- R 5 represents -CH 3 , -CH 2 CH 3 , -CH 2 CH 2 CH 3 , - (CH 2 ) 3 CH 3 , or -Tol.
- the saccharide, first saccharide and/or further saccharide is a saccharide building block consisting of a monosaccharide or disaccharide.
- the saccharide, first saccharide and/or further saccharide is a glycosyl donor consisting of a monosaccharide or disaccharide. More preferably, the saccharide, first saccharide and/or further saccharide is a protected glycosyl donor consisting of a monosaccharide or disaccharide.
- the saccharide, first saccharide and/or further saccharide is a saccharide building block consisting of a monosaccharide.
- the saccharide, first saccharide and/or further saccharide is a glycosyl donor consisting of a monosaccharide.
- the saccharide, first saccharide and/or further saccharide is a protected glycosyl donor consisting of a monosaccharide.
- the vapor of a solvent and a glycosylation agent is preferably applied to a solid support having a temperature below 5 °C, more preferably below 0°C, more preferably between -78 °C and 0 °C, more preferably between -30 °C and 0 °C, more preferably between -20 °C and 0 °C and more preferably between -20 °C and +5 °C.
- the ratio of the solvent and the glycosylation reagent in the vapor is preferably in the range of 1 : 10 to 100,000: 1 , more preferably in the range of 1 :1 to 100,000: 1 , more preferably in the range of 2: 1 to 100,000: 1 , more preferably in the range of 5: 1 to 100,000: 1 , and most preferably in the range of 10: 1 to 100,000: 1 .
- the vapor mixture is preferably prepared from a solution or a mixture of a glycosylation reagent in an aprotic organic solvent wherein the ratio of the solvent and the glycosylation reagent in the solution or mixture (i.e. bulk) is preferably in the range of 10:10 to 1 ,000,000: 1 , more preferably in the range of 10: 1 to 1 ,000,000: 1 , more preferably in the range of 20: 1 to 1 ,000,000: 1 , more preferably in the range of 50: 1 to 1 ,000,000: 1 , and most preferably in the range of 100: 1 to 1 ,000,000: 1 .
- the vapor mixture of the solvent and the glycosylation reagent is applied in laminar flow onto the solid support in order to achieve convective condensation of the vapor mixture and to avoid diffusion of the discrete locations or spots on the solid support.
- an additional reagent for the glycosylation reaction is delivered together with the first saccharide onto the solid support.
- one aspect of the present invention is directed to a method for synthesizing saccharides comprising the steps:
- A1 providing a solid support with acceptor groups for reacting with a saccharide
- B1 delivering a first saccharide and an additional reagent onto the solid support
- C1 drying the solid support
- the additional reagent is /V-iodosuccinimide.
- the solvent in the vapor is preferably an aprotic organic solvent.
- the solvent is selected from methylene chloride, acetonitrile, chloroform, diethyl ether, 1 ,4-dioxane, methyl tert-butyl ether, toluene and ethyl acetate.
- the glycosylation reagent is preferably a Bnzsnsted acid or Lewis acid. More preferably, the glycosylation reagent is a Lewis acid.
- the glycosylation reagent is selected from: AgOTf, BF 3* OEt 2 , trimethylsilyl trifluoromethanesulfonate (TMSOTf), trifluoromethanesulfonic acid (TfOH), trifluoromethanesulfonic anhydride (Tf 2 0, triflic anhydride), lanthanoid(lll) triflates, NIS/AgOTf, NIS/TfOH or dimethyl(methylthio)sulfonium trifluoromethanesulfonate (DMTST).
- TMSOTf trimethylsilyl trifluoromethanesulfonate
- TfOH trifluoromethanesulfonic acid
- Tf 2 trifluoromethanesulfonic anhydride
- lanthanoid(lll) triflates NIS/AgOTf, NIS/TfOH or dimethyl(methylthio)sulfonium trifluoromethanesulfon
- the glycosylation reagent is selected from: trimethylsilyl trifluoromethanesulfonate (TMSOTf), trifluoromethanesulfonic acid (TfOH), trifluoromethanesulfonic anhydride (Tf 2 0, triflic anhydride), and NIS/TfOH.
- TMSOTf trimethylsilyl trifluoromethanesulfonate
- TfOH trifluoromethanesulfonic acid
- Tf 2 trifluoromethanesulfonic anhydride
- NIS/TfOH NIS/TfOH.
- washing steps E1 ), E2), 11 ) and I2) of the inventive methods described herein may be carried out in the presence of a base, preferably an amine base in order to prevent decomposition or cleavage of the saccharide from the solid support.
- the inventive method can further comprise a step of deprotecting the saccharide after steps C), J1 ) or J2),
- the protecting groups are defined herein, preferably said protecting groups are protecting groups for hydroxyl groups and/or protecting groups for amine groups.
- Preferred protecting groups for hydroxyl groups are acetyl, phenyl, benzyl, isopropylidene, benzylidene, benzoyl, p-methoxybenzyl, p-methoxybenzylidene, p-methoxyphenyl, p-bromobenzylidene, p-nitrophenyl, allyl, allyloxycarbonyl, monochloroacetyl, isopropyl, p-bromobenzyl, dimethoxytrityl, trityl, 2-naphthylmethyl, pivaloyl, triisopropylsilyl, fe/f-butyldimethylsilyl, fe/f-butyldiphenylsilyl, tert- butyl- methoxyphenylsilyl, triethylsilyl, trimethylsilyl, 2-trimethylsilylethoxymethyl, 9-
- Preferred protecting groups for amine groups are acetyl, benzyl, p-methoxyphenyl, benzoyl, p-methoxybenzyl, 3,4-dimethoxybenzyl, benzyloxycarbonyl(Cbz), allyloxycarbonyl, trichloroacetyl (TCA), trifluoroacetyl, trichloroethyl(Troc), p- bromobenzyl, dimethoxytrityl, trityl, 2-naphthylmethyl, pivaloyl, 9- fluorenylmethoxycarbonyl (Fmoc), tert-butyloxycarbonyl(BOC), levulinoyl, tosyl, nosyl, 2-nitrophenylsulfenyl (Nps), and phthalimidyl.
- the method for synthesizing saccharides comprises the steps:
- A1 providing a solid support with acceptor groups for reacting with a saccharide
- B1 delivering a first saccharide onto the solid support
- A1 providing a solid support with acceptor groups for reacting with a saccharide
- B1 delivering a first saccharide onto the solid support
- Another aspect of the present invention is directed to the parallelized synthesis of saccharides on a solid support.
- the saccharide building blocks which are unreactive, are delivered first on the solid support and subsequently the coupling reaction is carried out by exposing the saccharide building blocks to a vapor comprising a solvent and a glycosylation reagent at low temperatures.
- the vapor condenses on the solid support and initiates the coupling reaction, thereby allowing the simultaneous synthesis of different saccharides at discrete locations on the solid support.
- the present invention is also directed to a method for producing saccharide arrays comprising the steps of
- the method for producing saccharide arrays comprises the steps of
- the method for producing saccharide arrays comprises the steps of
- the method for producing saccharide arrays comprises the steps of
- the method for producing saccharide arrays comprises the steps of
- the method for producing saccharide arrays comprises the steps of
- ratio of the solvent and the glycosylation reagent in the vapor is in the range of 1 : 10 to 100,000: 1.
- the method for producing saccharide arrays comprises the steps of
- the solvent is an aprotic organic solvent selected from: methylene chloride, acetonitrile, chloroform, diethyl ether, 1 ,4-dioxane, methyl tert-butyl ether, toluene and ethyl acetate.
- the method for producing saccharide arrays comprises the steps of
- glycosylation reagent is a Lewis acid selected from: AgOTf, BF 3* OEt 2 , trimethylsilyl trifluoromethanesulfonate (TMSOTf), trifluoromethanesulfonic acid (TfOH), trifluoromethanesulfonic anhydride (Tf 2 0, triflic anhydride), lanthanoid(lll) triflates, NIS/AgOTf, NIS/TfOH or dimethyl(methylthio)sulfonium trifluoromethane sulfonate (DMTST), preferably trimethylsilyl trifluoromethanesulfonate (TMSOTf), trifluoromethanesulfonic acid (TfOH), trifluoromethanesulfonic anhydride, or NIS/TfOH.
- TMSOTf trimethylsilyl trifluoromethanesulfonate
- TfOH trifluoromethanesulfonic acid
- the method for producing saccharide arrays comprises the steps of
- the at least one saccharide is a protected glycosyl donor comprising a glycal, epoxide or orthoester group or having a leaving group at the reducing end selected
- the method for producing saccharide arrays comprises the steps of
- the method for producing saccharide arrays comprises the steps of
- R 5 represents -CH 3 , -CH 2 CH 3 , -CH 2 CH 2 CH 3 , -(CH 2 ) 3 CH 3 , or -Tol.
- the method for producing saccharide arrays comprises the steps of
- step B) wherein in step B) the at least one saccharide is delivered as a solid, from a solution or in a polymer matrix onto the solid support.
- the method for producing saccharide arrays comprises the steps of A) providing a solid support having a plurality of acceptor groups for reacting with a saccharide at discrete locations immobilized thereto;
- the method for producing saccharide arrays comprises the steps of
- the method for producing saccharide arrays comprises the steps of
- the method for producing saccharide arrays comprises the steps of A) providing a solid support having a plurality of acceptor groups for reacting with a saccharide at discrete spots immobilized thereto;
- the method for producing saccharide arrays comprises the steps of
- solid support is a cellulose membrane with acceptor groups comprising glycosyl acceptors as defined herein.
- the method for producing saccharide arrays comprises the steps of
- the method for producing saccharide arrays comprises the steps of
- the method for producing saccharide arrays comprises the steps of
- the method for producing saccharide arrays comprises the steps of
- the method for producing saccharide arrays comprises the steps of A2) providing a solid support having acceptor groups for covalently attaching a saccharide at discrete spots;
- R 5 represents -CH 3 , -CH 2 CH 3 , -CH 2 CH 2 CH 3 , -(CH 2 ) 3 CH 3 , or -Tol.
- Another aspect of the present invention is directed to the provision of high-density saccharide arrays.
- the inventors found out that under coupling reaction conditions of the inventive method the delivered saccharide building blocks do not migrate or dissipate on the solid support, thereby a high-density pattern or array of the delivered saccharides is maintained, which renders the present invention particularly useful for the provision of saccharide arrays, particularly high-density saccharide arrays having a pitch of less than 300 pm.
- the present invention is also directed to a method for producing high-density saccharide arrays, comprising the steps of:
- A3')providing a donor support comprising a film layer, in which at least one saccharide is present, and an intermediate layer between the support and the film layer,
- step A3 selectively transferring of material of the at least one saccharide from the donor support to the solid support of step A3) and site-specific fixing of the transferred material to the discrete spots of the solid support by electromagnetic irradiation comprising laser light;
- the method for producing high-density saccharide arrays comprises the steps of:
- A3')providing a donor support comprising a film layer, in which at least one saccharide is present, and an intermediate layer between the support and the film layer,
- step A3 selectively transferring of material of the at least one saccharide from the donor support to the solid support of step A3) and site-specific fixing of the transferred material to the discrete spots of the solid support by electromagnetic irradiation comprising laser light;
- acceptor groups comprises a saccharide, preferably glycosyl acceptor, suitable for reacting with a saccharide as defined herein.
- the method for producing high-density saccharide arrays comprises the steps of:
- A3')providing a donor support comprising a film layer, in which at least one saccharide is present, and an intermediate layer between the support and the film layer,
- step A3 selectively transferring of material of the at least one saccharide from the donor support to the solid support of step A3) and site-specific fixing of the transferred material to the discrete spots of the solid support by electromagnetic irradiation comprising laser light;
- step B3 drying the solid support obtained in step B3) under reduced pressure and/or heating;
- the method for producing high-density saccharide arrays comprises the steps of:
- A3')providing a donor support comprising a film layer, in which at least one saccharide is present, and an intermediate layer between the support and the film layer,
- step B3) selectively transferring of material of the at least one saccharide from the donor support to the solid support of step A3) and site-specific fixing of the transferred material to the discrete spots of the solid support by electromagnetic irradiation comprising laser light;
- the method for producing high-density saccharide arrays comprises the steps of:
- A3')providing a donor support comprising a film layer, in which at least one saccharide is present, and an intermediate layer between the support and the film layer,
- step A3 selectively transferring of material of the at least one saccharide from the donor support to the solid support of step A3) and site-specific fixing of the transferred material to the discrete spots of the solid support by electromagnetic irradiation comprising laser light;
- the method for producing high-density saccharide arrays comprises the steps of:
- A3) providing a solid support with acceptor groups immobilized at discrete spots for reacting with a saccharide, and A3')providing a donor support comprising a film layer, in which at least one saccharide is present, and an intermediate layer between the support and the film layer,
- step A3 selectively transferring of material of the at least one saccharide from the donor support to the solid support of step A3) and site-specific fixing of the transferred material to the discrete spots of the solid support by electromagnetic irradiation comprising laser light;
- ratio of the solvent and the glycosylation reagent in the vapor is in the range of 1 : 10 to 100,000: 1.
- the method for producing high-density saccharide arrays comprises the steps of:
- A3')providing a donor support comprising a film layer, in which at least one saccharide is present, and an intermediate layer between the support and the film layer,
- step A3 selectively transferring of material of the at least one saccharide from the donor support to the solid support of step A3) and site-specific fixing of the transferred material to the discrete spots of the solid support by electromagnetic irradiation comprising laser light;
- the solvent is an aprotic organic solvent selected from: methylene chloride, acetonitrile, chloroform, diethyl ether, 1 ,4-dioxane, methyl tert-butyl ether, toluene and ethyl acetate.
- the method for producing high-density saccharide arrays comprises the steps of:
- A3')providing a donor support comprising a film layer, in which at least one saccharide is present, and an intermediate layer between the support and the film layer,
- step A3 selectively transferring of material of the at least one saccharide from the donor support to the solid support of step A3) and site-specific fixing of the transferred material to the discrete spots of the solid support by electromagnetic irradiation comprising laser light;
- the solvent is an aprotic organic solvent selected from: methylene chloride, acetonitrile, chloroform, diethyl ether, 1 ,4-dioxane, methyl tert-butyl ether, toluene and ethyl acetate.
- the method for producing high-density saccharide arrays comprises the steps of:
- A3')providing a donor support comprising a film layer, in which at least one saccharide is present, and an intermediate layer between the support and the film layer,
- step A3 selectively transferring of material of the at least one saccharide from the donor support to the solid support of step A3) and site-specific fixing of the transferred material to the discrete spots of the solid support by electromagnetic irradiation comprising laser light;
- glycosylation reagent is a Lewis acid selected from: AgOTf, BF 3* OEt 2 , trimethylsilyl trifluoromethanesulfonate (TMSOTf), trifluoromethanesulfonic acid (TfOH), trifluoromethanesulfonic anhydride (Tf 2 0, triflic anhydride), lanthanoid(lll) triflates, NIS/AgOTf, NIS/TfOH or dimethyl(methylthio)sulfonium trifluoromethane sulfonate (DMTST), preferably trimethylsilyl trifluoromethanesulfonate (TMSOTf), trifluoromethanesulfonic acid (TfOH), trifluoromethanesulfonic anhydride, or NIS/TfOH.
- TMSOTf trimethylsilyl trifluoromethanesulfonate
- TfOH trifluoromethanesulfonic acid
- the method for producing high-density saccharide arrays comprises the steps of:
- A3')providing a donor support comprising a film layer, in which at least one saccharide is present, and an intermediate layer between the support and the film layer,
- step A3 selectively transferring of material of the at least one saccharide from the donor support to the solid support of step A3) and site-specific fixing of the transferred material to the discrete spots of the solid support by electromagnetic irradiation comprising laser light;
- the method for producing high-density saccharide arrays comprises the steps of:
- A3')providing a donor support comprising a film layer, in which at least one saccharide is present, and an intermediate layer between the support and the film layer,
- step A3 selectively transferring of material of the at least one saccharide from the donor support to the solid support of step A3) and site-specific fixing of the transferred material to the discrete spots of the solid support by electromagnetic irradiation comprising laser light;
- the method for producing high-density saccharide arrays comprises the steps of:
- A3')providing a donor support comprising a film layer, in which at least one saccharide is present, and an intermediate layer between the support and the film layer,
- step A3 selectively transferring of material of the at least one saccharide from the donor support to the solid support of step A3) and site-specific fixing of the transferred material to the discrete spots of the solid support by electromagnetic irradiation comprising laser light;
- the selective transfer and the site-specific fixing of the at least one saccharide molecule from the donor support to the solid support is without direct contact between the supports and the at least one saccharide molecule is transferred in liquid or gaseous form
- the intermediate layer comprises polyimide, polycaprolactone, polystyrene or polyethylene.
- the method for producing high-density saccharide arrays comprises the steps of:
- A3')providing a donor support comprising a film layer, in which at least one saccharide is present, and an intermediate layer between the support and the film layer,
- step A3 selectively transferring of material of the at least one saccharide from the donor support to the solid support of step A3) and site-specific fixing of the transferred material to the discrete spots of the solid support by electromagnetic irradiation comprising laser light;
- the selective transfer and the site-specific fixing of the at least one saccharide molecule from the donor support to the solid support is without direct contact between the supports and the at least one saccharide molecule is transferred in liquid or gaseous form
- the intermediate layer comprises polyimide, polycaprolactone, polystyrene or polyethylene.
- the laser light is applied with a power output between 50 mW to 150 mW, preferably between 75 mW to 125 mW, most preferably 100 mW.
- the focus diameter of the laser light in step B3) is in the range of 5 pm to 70 pm, preferably between 10 pm to 50 pm, most preferably 20 pm.
- the pulse duration of the laser light applied in step B3) is between 1 ms to 20 ms, preferably 5 ms to 10 ms, most preferably 7 ms.
- the laser light is applied with a power output between 50 mW to 150 mW, with a focus diameter between 5 pm to 70 pm, and a pulse duration between 1 ms to 20 ms.
- Saccharides and particularly glycans are an important class of vaccines and antibody binders and are particularly useful as markers in immunological assays for detection of antibodies or glycan-binding proteins, such as lectins, against pathogens containing in their capsule the respective saccharide or a fragment thereof.
- Glycan-binding proteins which are not glycan-specific antibodies, can be either lectins and sulfated glycosaminoglycan (GAG)-binding proteins.
- Such assays comprise, for instance, glycan microarray or ELISA.
- an aspect of the present invention is directed to a method of detecting antibodies glycan-binding proteins in a test sample comprising contacting the test sample with a saccharide array obtained by an inventive method described herein and observing whether one or more saccharides or glycans are bound by an antibody in the test sample.
- the glycan microarrays obtained from the inventive methods described herein can be used in any common binding (competitive or non competitive) assay known in the art (e.g. as described in Chem Biol, 2014, 38-50).
- Binding may be detected by direct fluorescence, wherein the antibody or glycan- binding protein is conjugated to a fluorophore or indirect fluorescence, wherein a secondary antibody directed against the primary antibody or glycan-binding protein is conjugated to a fluorophore, such as fluorescein isothiocyanate (FITC).
- FITC fluorescein isothiocyanate
- the present invention is also directed to a method of detecting antibodies or glycan-binding proteins in a test sample comprising contacting the test sample with a saccharide array and observing whether one or more saccharides are bound by an antibody or glycan-binding protein in the test sample, wherein the saccharide array is prepared by the following steps comprising
- the present invention is directed to a method of detecting antibodies or glycan-binding proteins in a test sample comprising contacting the test sample with a saccharide array and observing whether one or more saccharides are bound by an antibody or glycan-binding protein in the test sample, wherein the saccharide array is prepared by the following steps comprising
- the present invention is directed to a method of detecting antibodies or glycan-binding proteins in a test sample comprising contacting the test sample with a saccharide array and observing whether one or more saccharides are bound by an antibody or glycan-binding protein in the test sample, wherein the saccharide array is prepared by the following steps comprising
- binding of the antibody to the one or more saccharides is observed by direct or indirect fluorescence.
- the present invention is directed to a method of detecting antibodies or glycan-binding proteins in a test sample comprising contacting the test sample with a saccharide array and observing whether one or more saccharides are bound by an antibody or saccharide-binding protein in the test sample, wherein the saccharide array is prepared by the following steps comprising
- step B) delivering at least one saccharide at the discrete locations on the surface of the solid support; C) drying the solid support obtained in step B) under reduced pressure and/or heating;
- the present invention is directed to a method of detecting antibodies or glycan-binding proteins in a test sample comprising contacting the test sample with a saccharide array and observing whether one or more saccharides are bound by an antibody or saccharide-binding protein in the test sample, wherein the saccharide array is prepared by the following steps comprising
- the present invention is directed to a method of detecting antibodies or glycan-binding proteins in a test sample comprising contacting the test sample with a saccharide array and observing whether one or more saccharides are bound by an antibody or glycan-binding protein in the test sample, wherein the saccharide array is prepared by the following steps comprising
- step C) applying a vapor of a solution of a glycosylation reagent in a solvent onto the solid support at a temperature below 20°C in order to initiate a coupling reaction of the at least one saccharide to the plurality of acceptor groups immobilized at discrete locations to the solid support; K) performing removal of protecting groups from the saccharide obtained in step C).
- the present invention is directed to a method of detecting antibodies or glycan-binding proteins in a test sample comprising contacting the test sample with a saccharide array and observing whether one or more saccharides are bound by an antibody or glycan-binding protein in the test sample, wherein the saccharide array is prepared by the following steps comprising
- the present invention is directed to a method of detecting antibodies or glycan-binding proteins in a test sample comprising contacting the test sample with a saccharide array and observing whether one or more saccharides are bound by an antibody or glycan-binding protein in the test sample, wherein the saccharide array is prepared by the following steps comprising
- ratio of the solvent and the glycosylation reagent in the vapor is in the range of 1 : 10 to 100,000: 1.
- the present invention is directed to a method of detecting antibodies or glycan-binding proteins in a test sample comprising contacting the test sample with a saccharide array and observing whether one or more saccharides are bound by an antibody or glycan-binding protein in the test sample, wherein the saccharide array is prepared by the following steps comprising
- the solvent is an aprotic organic solvent selected from: methylene chloride, acetonitrile, chloroform, diethyl ether, 1 ,4-dioxane, methyl tert-butyl ether, toluene and ethyl acetate.
- the present invention is directed to a method of detecting antibodies or glycan-binding proteins in a test sample comprising contacting the test sample with a saccharide array and observing whether one or more saccharides are bound by an antibody or glycan-binding protein in the test sample, wherein the saccharide array is prepared by the following steps comprising
- glycosylation reagent is a Lewis acid selected from: AgOTf, BF 3* OEt 2 , trimethylsilyl trifluoromethanesulfonate (TMSOTf), trifluoromethanesulfonic acid (TfOH), trifluoromethanesulfonic anhydride (Tf 2 0, triflic anhydride), lanthanoid(lll) triflates, NIS/AgOTf, NIS/TfOH or dimethyl(methylthio)sulfonium trifluoromethane sulfonate (DMTST), preferably trimethylsilyl trifluoromethanesulfonate (TMSOTf), trifluoromethanesulfonic acid (TfOH), trifluoromethanesulfonic anhydride, or NIS/TfOH.
- TMSOTf trimethylsilyl trifluoromethanesulfonate
- TfOH trifluoromethanesulfonic acid
- the present invention is directed to a method of detecting antibodies or glycan-binding proteins in a test sample comprising contacting the test sample with a saccharide array and observing whether one or more saccharides are bound by an antibody or glycan-binding protein in the test sample, wherein the saccharide array is prepared by the following steps comprising A) providing a solid support having a plurality of acceptor groups for reacting with a saccharide at discrete locations immobilized thereto;
- the at least one saccharide is a protected glycosyl donor comprising a glycal, epoxide or orthoester group or having a leaving group at the reducing end selected
- the present invention is directed to a method of detecting antibodies or glycan-binding proteins in a test sample comprising contacting the test sample with a saccharide array and observing whether one or more saccharides are bound by an antibody or glycan-binding protein in the test sample, wherein the saccharide array is prepared by the following steps comprising
- the present invention is directed to a method of detecting antibodies or glycan-binding proteins in a test sample comprising contacting the test sample with a saccharide array and observing whether one or more saccharides are bound by an antibody or glycan-binding protein in the test sample, wherein the saccharide array is prepared by the following steps comprising
- step B) wherein in step B) the at least one saccharide is delivered as a solid, from a solution or in a polymer matrix onto the solid support.
- the present invention is directed to a method of detecting antibodies or glycan-binding proteins in a test sample comprising contacting the test sample with a saccharide array and observing whether one or more saccharides are bound by an antibody or glycan-binding protein in the test sample, wherein the saccharide array is prepared by the following steps comprising
- the present invention is directed to a method of detecting antibodies or glycan-binding proteins in a test sample comprising contacting the test sample with a saccharide array and observing whether one or more saccharides are bound by an antibody or glycan-binding protein in the test sample, wherein the saccharide array is prepared by the following steps comprising
- step B) delivering a solution of at least one saccharide at the discrete spots on the surface of the solid support; C) drying the solid support obtained in step B) under reduced pressure and/or heating;
- the present invention is directed to a method of detecting antibodies or glycan-binding proteins in a test sample comprising contacting the test sample with a saccharide array and observing whether one or more saccharides are bound by an antibody or glycan-binding protein in the test sample, wherein the saccharide array is a high-density saccharide array prepared by the following steps comprising
- A3')providing a donor support comprising a film layer, in which at least one saccharide is present, and an intermediate layer between the support and the film layer,
- step A3 selectively transferring of material of the at least one saccharide from the donor support to the solid support of step A3) and site-specific fixing of the transferred material to the discrete spots of the solid support by electromagnetic irradiation comprising laser light;
- a further aspect of the present invention is directed to a saccharide synthesizer comprising:
- the substrate having a surface and being configured to support a solid support with at least one immobilized acceptor group for reacting with a saccharide;
- a vapor supply in fluid communication with the process space, the vapor supply configured to supply a vapor comprising a solvent and a glycosylation reagent to the process space;
- a cooling element positioned within the processing chamber configured to cool the solid support by heat transfer through the substrate
- an exhaust port in the processing chamber configured in fluid communication with an isolation valve
- a purge gas supply in fluid communication with the process space, the purge gas supply configured to supply a purge gas to the process space effective to displace the vapor from the process space,
- the substrate is positioned in the process space of the chamber.
- the means for delivering a saccharide to a solid support comprises a capillary needle which is in fluid connection with a reservoir containing a saccharide, optionally a syringe connected to said capillary needle, or optionally a microactuator connected to said capillary needle; or a laser for transferring the saccharide in a polymer matrix onto the solid support.
- a saccharide synthesizer comprising:
- the substrate having a surface and being configured to support a solid support with at least one immobilized acceptor group for reacting with a saccharide;
- a vapor supply in fluid communication with the process space, the vapor supply configured to supply a vapor comprising a solvent and a glycosylation reagent to the process space; a cooling element positioned within the processing chamber configured to cool the solid support by heat transfer through the substrate;
- an exhaust port in the processing chamber configured in fluid communication with an isolation valve
- a purge gas supply in fluid communication with the process space, the purge gas supply configured to supply a purge gas to the process space effective to displace the vapor from the process space,
- the means for delivering a saccharide to a solid support comprises a capillary needle which is in fluid connection with a reservoir containing a saccharide, optionally a syringe connected to said capillary needle, or optionally a microactuator connected to said capillary needle; or a laser for transferring the saccharide in a polymer matrix onto the solid support.
- the cooling element of the chamber is capable of cooling the solid support below a temperature of 5°C.
- the present invention is directed to a saccharide synthesizer comprising:
- the substrate having a surface and being configured to support a solid support with at least one immobilized acceptor group for reacting with a saccharide;
- a vapor supply in fluid communication with the process space, the vapor supply configured to supply a vapor comprising a solvent and a glycosylation reagent to the process space;
- a cooling element positioned within the processing chamber configured to cool the solid support by heat transfer through the substrate
- an exhaust port in the processing chamber configured in fluid communication with an isolation valve
- a purge gas supply in fluid communication with the process space, the purge gas supply configured to supply a purge gas to the process space effective to displace the vapor from the process space,
- the substrate is positioned in the process space of the chamber, and wherein the cooling element of the chamber cools the solid support below a temperature of 5°C.
- Figures 6A, B and C show some configurations of the chamber of the inventive synthesizer.
- the chamber comprises at least one inlet for vapor supply or purge gas supply and one outlet (exhaust port) for displacing the vapor or applying a vacuum.
- the vapor supply and the purge gas supply are in fluid communication with the process space via a valve.
- the vapor supply is arranged on a side wall of the chamber.
- the vapor supply is configured to apply a laminar flow of the vapor onto the solid support.
- the at least one inlet for vapor supply and the one outlet (exhaust port) for displacing the vapor or applying a vacuum are arranged on top of the chamber.
- the e at least one inlet for vapor supply and the one outlet (exhaust port) for displacing the vapor or applying a vacuum are located at opposite positions of the top of the chamber in order to allow a laminar flow of the vapor onto the solid support.
- the saccharide synthesizer comprises:
- the substrate having a surface and being configured to support a solid support with at least one immobilized acceptor group for reacting with a saccharide;
- a vapor supply in fluid communication with the process space, the vapor supply configured to supply a vapor comprising a solvent and a glycosylation reagent in laminar flow to the process space;
- a cooling element positioned within the processing chamber configured to cool the solid support by heat transfer through the substrate
- an exhaust port in the processing chamber configured in fluid communication with an isolation valve
- a purge gas supply in fluid communication with the process space, the purge gas supply configured to supply a purge gas to the process space effective to displace the vapor from the process space,
- the substrate is positioned in the process space of the chamber and wherein the vapor supply and the purge gas supply are in fluid communication with the process space via a valve.
- a further aspect of the present invention is directed to a system for producing saccharides comprising 1 ) a saccharide synthesizer comprising:
- the substrate having a surface and being configured to support a solid support with at least one immobilized acceptor group for reacting with a saccharide;
- vapor supply in fluid communication with the process space, the vapor supply configured to supply a vapor comprising a solvent and a glycosylation reagent to the process space;
- cooling element positioned within the processing chamber configured to cool the solid support by heat transfer through the substrate
- the purge gas supply configured to supply a purge gas to the process space effective to displace the vapor from the process space
- the substrate is positioned in the process space of the chamber
- Figure 1 illustrates the inventive method for producing a saccharide on a cellulose membrane by spotting a solution of saccharide building block on to the cellulose membrane.
- Figure 2 illustrates the inventive method for high-throughput synthesis of a high- density saccharide array.
- Figure 3 provides examples of commercially available anchoring groups.
- Figure 4 provides examples of interconnecting molecules for immobilizing saccharides to solid support.
- Figure 5 shows the structures of exemplarily saccharide building blocks which can be used in the present invention.
- FIG. 6A, B and C illustrate different embodiments of the chamber of the inventive synthesizer.
- Figure 7 shows the preparation of acceptor slide for laser transfer of a glycosyl donor.
- Figure 8 shows a setup of a vapor annealing coupling chamber and a vapor generator
- the U-shaped vapor generator comprises a frit, a gas inlet, a gas outlet, an inlet for glycosylation reagent located above the frit, the generator is located in a water bath of 50 °C
- the coupling chamber is equipped with a thermoelectric cooling element for controlling the reaction temperature, wherein the temperature can be controlled with a computer.
- Figure 9 shows the reaction scheme of a vapor-triggered glycosylation on a slide.
- Figure 10 shows complete disaccharide synthesis on glass slide using the inventive method.
- Figure 11 shows an alternative setup of a vapor annealing coupling chamber.
- Figure 12 shows MALDI-TOF-MS spectra after vapor-triggered glycosylation.
- disaccharide obtained by glycosylation of trichloroacetimidate 8 with functionalized cellulose membrane A; on the right, direct glycosylation of phosphate on functionalized polypropylene membrane B.
- Figure 13 shows MALDI-TOF-MS spectra of compound 10.
- Figure 14 Parameters for the spotting of glycosyl donor dissolved in dichloro- methane.
- a solution of 200 mg of the building block in dichloromethane will be used.
- PG protecting group
- LG leaving group.
- Figure 15 shows MALDI-TOF MS spectra: upper spectrum corresponds to the membrane area where only the glucose donor 13 was spotted; lower spectrum: corresponds to the membrane area where only the mannose donor 8 was spotted.
- Example 1 Optimization of Vapor triggered glycosylation on a functionalized glass slide
- Acceptor slide preparation Commercially available amine-functionalized glass slides from PolyAn GmbH were used as acceptor slides. The slides were functionalized with a Cn-spacer (see Figure 7) in presence of diisopropyl- carbodiimide (DIC) and hydroxybenzotriazole (HOBt) by contacting two slides with the Fmoc-protected Cn-spacer 4 in between (sandwich) overnight. Unreacted free amine groups on the slide surface were capped using a mixture of Ac 2 0/DIPEA/DMF. Fmoc-group of the Cn-spacer was removed by treating the slide with 20% piperidine in DMF.
- DIC diisopropyl- carbodiimide
- HOBt hydroxybenzotriazole
- Galactose acceptor molecule 6 was coupled to the C11 -acceptor in presence of DIC and FIOBt by contacting two slides with the acceptor 6 in between (sandwich) overnight. Unreacted amino groups were capped using a mixture of AC 2 0/D I PEA/DM F. The Fmoc group was removed treating the slide with 20% piperidine in DMF.
- Donor slide preparation All donor slides were generated by spin-coating a solution of the glycosyl donor 8 (building block) and an inert polymer matrix (SLEC PLT 7552, Sekisui Chemical GmbFI, Diisseldorf/Germany) in dichloromethane on a glass slide covered with a polyimide foil (Kapton®).
- the inert polymer matrix forms a protective layer and shields the building block from environmental influences, while the Kapton® foil is needed for laser light absorption and heat induction.
- the donor composition is shown in table 1 below.
- the glycosyl imidate 8 was transferred with laser induced forward transfer (cLIFT) onto the acceptor slide using the following laser parameters: 100 mW, 20 pm focus diameter, 7 ms pulse duration, 200 pm spot pitch.
- cLIFT laser induced forward transfer
- the donor slide was placed on top of the acceptor, and the laser light reached the Kapton® foil.
- the heat which is produced via laser irradiation, deforms the donor slide, thus bringing the two layers in contact.
- the Kapton® foil which is stable under short-term heat exposure, expands slightly due to the heat from the laser, transferring the desired compound from the donor to the acceptor slide.
- the glycosylation solution containing dichloromethane and activator was bubbled for 2.3 min under inert atmosphere (Figure 8) until complete transfer of the solution inside the glycosylation-vapor chamber.
- Figure 8 The conditions for the glycosylation reaction are summarized in Table 2.
- the acceptor slide is left to react under vapor for 30 min in a closed setup. After completion, the acceptor-setup was warmed up to rt under vacuum. Then, the slide was removed from the setup and washed with dimethylformamide and dichloromethane. Deprotection of the benzoyl groups was accomplished under inert atmosphere using anhyd. methanol and K 2 CO 3 overnight.
- Example 2 Vapor triggered glycosylation on a functionalized glass slide 2.1 Acceptor slide preparation: The vapor triggered glycosylation reaction of a glycosyl donor and a glycosyl acceptor on a functionalized glass slide (solid support) was accomplished on a commercially available 3D amine microarray slide from PolyAn GmbH (Berlin). In this case also other functionalized glass slides from other companies like carboxyl- (NHS-activated or not), epoxy-, maleimide-, thiol-, azide-, hydroxyl-, tetrazine-, aldehyde- or alkyne-surfaces may be used.
- the functional groups can be used on the surfaces directly for the attachment of a linker, spacer, interconnecting molecule (see Figure 4) or saccharide building block (see Figure 5) or convert them into another functional group, which can then be used for connection between the above mentioned species and the glass slide.
- a linker, spacer, interconnecting molecule see Figure 4
- saccharide building block see Figure 5
- Another option would be a self-synthesized microarray glass slide for this approach.
- Photo-linker 2a 26.0 mg, 50 pmol
- Donor slide preparation First of all, the donor slide was prepared as followed for the laser induced forward transfer (cLIFT) of the glycosyl donor 8 (structure shown in Figure 10).
- cLIFT laser induced forward transfer
- the glycosyl imidate 8 was transferred with laser induced forward transfer (cLIFT) onto the acceptor slide 7 using the following laser parameters: 100 mW, 20 pm focus diameter, 7 ms pulse duration, 200 pm spot pitch.
- cLIFT laser induced forward transfer
- the whole surface area of the donor slide was transferred to the acceptor slide and for the detection of the molecules using fluorescently labeled Concanavalin A lectin (binds selectively to a- mannopyranosyl residues) a spot pattern was transferred to the acceptor slide (in this case no linker or spacer is needed). Thereby no coupling reaction is initiated, which is very important for the process.
- the amount of the building block which is transferred with this approach is typically in a micro to nanomolar range.
- Approach is typically in a micro to nanomolar range.
- the slide was taken out of the chamber, washed with different solvents and the molecule 10 was cleaved from the glass substrate via UV irradiation for the mass spectrometry approach and detected by MALDI-TOF-MS ( Figure 13).
- the result was visualized by incubation of the slide with fluorescently labeled Concanavalin A in a HEPES-buffer and subsequent fluorescence scan.
- Cellulose membranes functionalized with b-alanine were obtained from AIMS Scientific Products GmbH and polypropylene membranes (B, see 12B in scheme below) were obtained from AIMS Scientific Products GmbH (hydroxy-functionalized) and PolyAn GmbH (amino-functionalized).
- the membranes were functionalized with a photo cleavable linker 2a, a spacer 4 and the glycosyl imidate 6 to obtain modified cellulose and polypropylene membrane.
- An exemplarily modified cellulose membrane 12A is shown below:
- a cellulose membrane which was purchased from AIMS Scientific Products GmbH was modified to membrane 12 as described in Example 3. Two different glycosylation reactions were tested on membrane 12. The first one was performed with glycosyl imidate 8 applying the conditions shown below and the second with thioglycoside 16, conditions also shown below. Both reactions were done in solution to verify that the glycosylation reaction in general is possible on the cellulose membrane. For both reactions the glycosylation product (disaccharide) was detected via MALDI-TOF-MS after cleavage of the molecule from the membrane via UV irradiation.
- thermoelectric cooling element should be able to warm the surface up to +150 °C to remove these compounds under vacuum.
- the first bottle is heated to RT + DT to saturate the vapor.
- the second bottle is kept at RT, which results in 100 % saturated vapor.
- Condensation on the substrate The speed of vapor condensation on the sample surface is adjusted by the temperature difference DT (is
- ). Condensation occurs at DT 0 (vapor vs. sample), when the vapor saturation is 100 % or when DT > 0, the vapor condensates with saturation ⁇ 100 %.
- the reaction time is between 10 minutes up to one hour.
- the reactive support is quenched by adding a base (e.g. piperidine, triethylamine) within the reaction chamber. Then the substrate is removed of the chamber and washed. After the deprotection of a temporary protecting on the sugar moiety the substrate is used in the next CVAS glycosylation reaction.
- a base e.g. piperidine, triethylamine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Saccharide Compounds (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18213784.4A EP3670521A1 (en) | 2018-12-18 | 2018-12-18 | Method and device for producing saccharides and saccharide arrays |
| PCT/EP2019/085806 WO2020127391A1 (en) | 2018-12-18 | 2019-12-17 | Method and device for producing saccharides and saccharide arrays |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP3897958A1 true EP3897958A1 (en) | 2021-10-27 |
| EP3897958B1 EP3897958B1 (en) | 2023-06-21 |
Family
ID=64746012
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP18213784.4A Withdrawn EP3670521A1 (en) | 2018-12-18 | 2018-12-18 | Method and device for producing saccharides and saccharide arrays |
| EP19832336.2A Active EP3897958B1 (en) | 2018-12-18 | 2019-12-17 | Method and device for producing saccharides and saccharide arrays |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP18213784.4A Withdrawn EP3670521A1 (en) | 2018-12-18 | 2018-12-18 | Method and device for producing saccharides and saccharide arrays |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US11772063B2 (en) |
| EP (2) | EP3670521A1 (en) |
| CA (1) | CA3121368A1 (en) |
| DK (1) | DK3897958T3 (en) |
| WO (1) | WO2020127391A1 (en) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010011828A1 (en) * | 2008-07-23 | 2010-01-28 | Ancora Pharmaceuticals Inc. | Automated oligosaccharide synthesizer |
-
2018
- 2018-12-18 EP EP18213784.4A patent/EP3670521A1/en not_active Withdrawn
-
2019
- 2019-12-17 US US17/414,965 patent/US11772063B2/en active Active
- 2019-12-17 DK DK19832336.2T patent/DK3897958T3/en active
- 2019-12-17 EP EP19832336.2A patent/EP3897958B1/en active Active
- 2019-12-17 WO PCT/EP2019/085806 patent/WO2020127391A1/en not_active Ceased
- 2019-12-17 CA CA3121368A patent/CA3121368A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20220062849A1 (en) | 2022-03-03 |
| US11772063B2 (en) | 2023-10-03 |
| EP3670521A1 (en) | 2020-06-24 |
| WO2020127391A1 (en) | 2020-06-25 |
| EP3897958B1 (en) | 2023-06-21 |
| DK3897958T3 (en) | 2023-08-07 |
| CA3121368A1 (en) | 2020-06-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kushwaha et al. | Click reaction in carbohydrate chemistry: recent developments and future perspective | |
| Werz et al. | Carbohydrates as the next frontier in pharmaceutical research | |
| Rademann et al. | Repetitive solid phase glycosylation on an alkyl thiol polymer leading to sugar oligomers containing 1, 2-trans-and 1, 2-cis-glycosidic linkages | |
| Codée et al. | Automated solid‐phase synthesis of protected oligosaccharides containing β‐mannosidic linkages | |
| de Paz et al. | Oligosaccharide microarrays to map interactions of carbohydrates in biological systems | |
| Chevolot et al. | Immobilisation on polystyrene of diazirine derivatives of mono-and disaccharides: biological activities of modified surfaces | |
| Liang et al. | Elegant chemistry to directly anchor intact saccharides on solid surfaces used for the fabrication of bioactivity-conserved saccharide microarrays | |
| van Ameijde et al. | Synthesis of novel trivalent amino acid glycoconjugates based on the cyclotriveratrylene (‘CTV’) scaffold | |
| Bhattacharya et al. | A total synthesis of the methyl glycoside of ganglioside GM1 | |
| US20150177238A1 (en) | Process for the manufacturing of glycochips | |
| Haase et al. | Recent progress in polymer-supported synthesis of oligosaccharides and carbohydrate libraries | |
| EP3897958B1 (en) | Method and device for producing saccharides and saccharide arrays | |
| EP2405267A1 (en) | Surface-modified base plate, biochip and process for producing the biochip | |
| WO2008100553A1 (en) | Robust multidentate ligands for diagnosis and anti-viral drugs for influenza and related viruses | |
| Pawar et al. | Multivalent presentation of carbohydrates by 3 14-helical peptide templates: synthesis, conformational analysis using CD spectroscopy and saccharide recognition | |
| US20100331198A1 (en) | Photo-generated carbohydrate arrays and the rapid identification of pathogen-specific antigens and antibodies | |
| EP0939759A2 (en) | Saccharide derivatives | |
| US20050059728A1 (en) | Dithiolane derivatives for immobilising biomolecules on noble metals and semiconductors | |
| Awad et al. | C‐Linked Disaccharide Analogue of the Thomsen–Friedenreich (T)‐Epitope α‐O‐Conjugated to l‐Serine | |
| EP1971864A2 (en) | Kit comprising 2,4-dichlorophenoxyacetic acd derivatives and antibodies for highly sensitive detection assays | |
| WO2008042901A2 (en) | Preparation and uses of locked-ring sugar c-glycoside derivatives | |
| KR101101375B1 (en) | Immobilization Method of Sugars | |
| Tsouka | Development of Novel Technologies for Parallel Synthesis of Glycans and Glycopeptides for Microarray Generation | |
| WO1999058540A2 (en) | 1-galactose derivatives | |
| EP2645103A1 (en) | Glycopeptide array |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
| 17P | Request for examination filed |
Effective date: 20210608 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| DAV | Request for validation of the european patent (deleted) | ||
| DAX | Request for extension of the european patent (deleted) | ||
| GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
| INTG | Intention to grant announced |
Effective date: 20220719 |
|
| GRAJ | Information related to disapproval of communication of intention to grant by the applicant or resumption of examination proceedings by the epo deleted |
Free format text: ORIGINAL CODE: EPIDOSDIGR1 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
| INTC | Intention to grant announced (deleted) | ||
| GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
| GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
| INTG | Intention to grant announced |
Effective date: 20230120 |
|
| GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
| AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602019031457 Country of ref document: DE |
|
| REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 1580504 Country of ref document: AT Kind code of ref document: T Effective date: 20230715 |
|
| REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
| REG | Reference to a national code |
Ref country code: SE Ref legal event code: TRGR |
|
| REG | Reference to a national code |
Ref country code: DK Ref legal event code: T3 Effective date: 20230731 |
|
| REG | Reference to a national code |
Ref country code: NL Ref legal event code: FP |
|
| REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG9D |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230921 |
|
| REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 1580504 Country of ref document: AT Kind code of ref document: T Effective date: 20230621 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230621 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230621 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230621 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230621 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230922 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230621 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230621 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230621 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231021 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230621 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230621 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230621 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231023 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231021 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230621 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230621 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230621 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230621 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230621 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602019031457 Country of ref document: DE |
|
| PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230621 |
|
| 26N | No opposition filed |
Effective date: 20240322 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230621 Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230621 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231217 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230621 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230621 Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231217 |
|
| P01 | Opt-out of the competence of the unified patent court (upc) registered |
Free format text: CASE NUMBER: APP_47174/2024 Effective date: 20240814 |
|
| REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231217 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20231217 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230621 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230621 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20191217 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20191217 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230621 |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: U11 Free format text: ST27 STATUS EVENT CODE: U-0-0-U10-U11 (AS PROVIDED BY THE NATIONAL OFFICE) Effective date: 20260101 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20251119 Year of fee payment: 7 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20251218 Year of fee payment: 7 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DK Payment date: 20251217 Year of fee payment: 7 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 20251217 Year of fee payment: 7 Ref country code: FR Payment date: 20251217 Year of fee payment: 7 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: BE Payment date: 20251223 Year of fee payment: 7 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: SE Payment date: 20251217 Year of fee payment: 7 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 20260101 Year of fee payment: 7 |